The use of control group in the sports science research: the ethical challenge

Detalhes bibliográficos
Autor(a) principal: Louro,Gonçalo
Data de Publicação: 2023
Outros Autores: Ferraz,Ricardo, Forte,Pedro, Teixeira,José Eduardo, Branquinho,Luís, Esteves,Dulce
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-107X2023000100004
Resumo: Abstract Medical ethicists have questioned the use of no-treatment controlled studies (placebo and sham procedure) of new therapies when safe and effective standard therapies are available for use as an active or “equivalence” control. Currently, ethical and conduct principles for biomedical research specifically prohibit projects that do not make or deny the “best-proven diagnosis and therapeutic treatment” to any participant in a clinical trial, including individuals who consent to randomisation into a control group. Studies of psychophysiological therapies are often criticised for not having a placebo or sham treatment control group. In sports science research, particularly in the case of clinical exercise, the use of control groups also raises ethical questions. This article briefly reviews the problem and discusses the ethical standards governing human research derived from the Nuremberg Code and the Declaration of Helsinki.
id RCAP_3b7baeabccc5594664dea7783e128781
oai_identifier_str oai:scielo:S1646-107X2023000100004
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The use of control group in the sports science research: the ethical challengeethics of control groupplacebo controlrandomised controlled trialclinical exerciseAbstract Medical ethicists have questioned the use of no-treatment controlled studies (placebo and sham procedure) of new therapies when safe and effective standard therapies are available for use as an active or “equivalence” control. Currently, ethical and conduct principles for biomedical research specifically prohibit projects that do not make or deny the “best-proven diagnosis and therapeutic treatment” to any participant in a clinical trial, including individuals who consent to randomisation into a control group. Studies of psychophysiological therapies are often criticised for not having a placebo or sham treatment control group. In sports science research, particularly in the case of clinical exercise, the use of control groups also raises ethical questions. This article briefly reviews the problem and discusses the ethical standards governing human research derived from the Nuremberg Code and the Declaration of Helsinki.Edições Desafio Singular2023-03-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-107X2023000100004Motricidade v.19 n.1 2023reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-107X2023000100004Louro,GonçaloFerraz,RicardoForte,PedroTeixeira,José EduardoBranquinho,LuísEsteves,Dulceinfo:eu-repo/semantics/openAccess2024-02-06T17:20:38Zoai:scielo:S1646-107X2023000100004Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:27:56.369364Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The use of control group in the sports science research: the ethical challenge
title The use of control group in the sports science research: the ethical challenge
spellingShingle The use of control group in the sports science research: the ethical challenge
Louro,Gonçalo
ethics of control group
placebo control
randomised controlled trial
clinical exercise
title_short The use of control group in the sports science research: the ethical challenge
title_full The use of control group in the sports science research: the ethical challenge
title_fullStr The use of control group in the sports science research: the ethical challenge
title_full_unstemmed The use of control group in the sports science research: the ethical challenge
title_sort The use of control group in the sports science research: the ethical challenge
author Louro,Gonçalo
author_facet Louro,Gonçalo
Ferraz,Ricardo
Forte,Pedro
Teixeira,José Eduardo
Branquinho,Luís
Esteves,Dulce
author_role author
author2 Ferraz,Ricardo
Forte,Pedro
Teixeira,José Eduardo
Branquinho,Luís
Esteves,Dulce
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Louro,Gonçalo
Ferraz,Ricardo
Forte,Pedro
Teixeira,José Eduardo
Branquinho,Luís
Esteves,Dulce
dc.subject.por.fl_str_mv ethics of control group
placebo control
randomised controlled trial
clinical exercise
topic ethics of control group
placebo control
randomised controlled trial
clinical exercise
description Abstract Medical ethicists have questioned the use of no-treatment controlled studies (placebo and sham procedure) of new therapies when safe and effective standard therapies are available for use as an active or “equivalence” control. Currently, ethical and conduct principles for biomedical research specifically prohibit projects that do not make or deny the “best-proven diagnosis and therapeutic treatment” to any participant in a clinical trial, including individuals who consent to randomisation into a control group. Studies of psychophysiological therapies are often criticised for not having a placebo or sham treatment control group. In sports science research, particularly in the case of clinical exercise, the use of control groups also raises ethical questions. This article briefly reviews the problem and discusses the ethical standards governing human research derived from the Nuremberg Code and the Declaration of Helsinki.
publishDate 2023
dc.date.none.fl_str_mv 2023-03-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-107X2023000100004
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-107X2023000100004
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-107X2023000100004
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Edições Desafio Singular
publisher.none.fl_str_mv Edições Desafio Singular
dc.source.none.fl_str_mv Motricidade v.19 n.1 2023
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137350593282048

Registros relacionados